Browse by UCL people
Group by: Type | Date
Number of items: 211.
Article
(2015)
Once vs. twice-daily lopinavir/ritonavir in HIV-1-infected children.
AIDS
, 29
(18)
pp. 2447-2457.
10.1097/QAD.0000000000000862.
|
Abongomera, G;
Cook, A;
Musiime, V;
Chabala, C;
Lamorde, M;
Abach, J;
Thomason, M;
... CHAPAS-3 trial Team, .; + view all
(2016)
Improved adherence to antiretroviral therapy observed among HIV-infected children whose caregivers had positive beliefs in medicine in Sub-Saharan Africa.
AIDS and Behavior
10.1007/s10461-016-1582-8.
|
Ades, AE;
Gordon, Fabiana;
Scott, Karen;
Collins, Intira Jeannie;
Thorne, Claire;
Pembrey, Lucy;
Chappell, Elizabeth;
... Judd, Ali; + view all
(2022)
Spontaneous Clearance Of Vertically Acquired Hepatitis C Infection: Implications For Testing And Treatment.
Clinical Infectious Diseases
10.1093/cid/ciac255.
(In press).
|
Ades, Anthony E;
Gordon, Fabiana;
Scott, Karen;
Collins, Intira J;
Thorne, Claire;
Pembrey, Lucy;
Chappell, Elizabeth;
... Judd, Ali; + view all
(2022)
Overall vertical transmission of HCV, transmission net of clearance, and timing of transmission.
Clinical Infectious Diseases
10.1093/cid/ciac270.
(In press).
|
Aramburo, A;
Todd, J;
George, EC;
Kiguli, S;
Olupot- Olupot, P;
Opoka, RO;
Engoru, C;
... Maitland, K; + view all
(2018)
Lactate clearance as a prognostic marker of mortality in severely ill febrile children in East Africa.
BMC Medicine
, 16
(37)
10.1186/s12916-018-1014-x.
|
Asad, H;
Collins, IJ;
Goodall, RL;
Crichton, S;
Hill, T;
Doerholt, K;
Foster, C;
... Collaborative HIV Paediatric Study (CHIPS) Steering Committee, t; + view all
(2021)
Mortality and AIDS-defining events among young people following transition from paediatric to adult HIV care in the UK.
HIV Medicine
10.1111/hiv.13096.
(In press).
|
Atkinson, A;
Miro, JM;
Mocroft, A;
Reiss, P;
Kirk, O;
Morlat, P;
Ghosn, J;
... Opportunistic Infections Working Group of the Collaboration of O, .; + view all
(2021)
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL.
Journal of the International AIDS Society
, 24
(6)
, Article e25726. 10.1002/jia2.25726.
|
Atkinson, A;
Zwahlen, M;
Barger, D;
d'Arminio Monforte, A;
De Wit, S;
Ghosn, J;
Girardi, E;
... Opportunistic Infections Project Working Group of the Collaborat, .; + view all
(2020)
Withholding primary PcP prophylaxis in virologically suppressed HIV patients: An emulation of a pragmatic trial in COHERE.
Clinical Infectious Diseases
10.1093/cid/ciaa615.
(In press).
|
Bamford, A;
Turkova, A;
Lyall, H;
Foster, C;
Klein, N;
Bastiaans, D;
Burger, D;
... Welch, S; + view all
(2018)
Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: Optimizing health in preparation for adult life.
HIV Medicine
, 19
(1)
e1-e42.
10.1111/hiv.12217.
|
Barratt, S;
Bielicki, JA;
Dunn, D;
Faust, SN;
Finn, A;
Harper, L;
Jackson, P;
... Sharland, M; + view all
(2021)
Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT.
Health Technology Assessment
, 25
(60)
10.3310/hta25600.
|
Basu Roy, R;
Bakeera-Kitaka, S;
Chabala, C;
Gibb, DM;
Huynh, J;
Mujuru, H;
Sankhyan, N;
... Anderson, ST; + view all
(2021)
Defeating Paediatric Tuberculous Meningitis: Applying the WHO "Defeating Meningitis by 2030: Global Roadmap".
Microorganisms
, 9
(4)
, Article 857. 10.3390/microorganisms9040857.
|
Bernays, S;
Paparini, S;
Seeley, J;
Namukwaya Kihika, S;
Gibb, DM;
Rhodes, T;
(2017)
Qualitative study of the BREATHER trial (Short Cycle antiretroviral therapy): is it acceptable to young people living with HIV?
BMJ Open
, 7
(2)
, Article e012934. 10.1136/bmjopen-2016-012934.
|
Bevers, Lisanne AH;
Waalewijn, Hylke;
Szubert, Alexander J;
Chabala, Chishala;
Bwakura-Dangarembizi, Mutsa;
Makumbi, Shafic;
Nangiya, Joan;
... Colbers, Angela; + view all
(2023)
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial.
Clinical Infectious Diseases
10.1093/cid/ciad346.
(In press).
|
|
Bielicki, JA;
Stöhr, W;
Barratt, S;
Dunn, D;
Naufal, N;
Roland, D;
Sturgeon, K;
... PERUKI, GAPRUKI, and the CAP-IT Trial Group, .; + view all
(2021)
Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia
The CAP-IT Randomized Clinical Trial.
JAMA
, 326
(17)
pp. 1713-1724.
10.1001/jama.2021.17843.
|
Bienczak, A;
Cook, A;
Wiesner, L;
Mulenga, V;
Kityo, C;
Kekitiinwa, A;
Walker, AS;
... Denti, P; + view all
(2016)
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children.
Journal of Antimicrobial Chemotherapy
, 72
(1)
pp. 190-199.
10.1093/jac/dkw388.
|
Bienczak, A;
Cook, A;
Wiesner, L;
Olagunju, A;
Mulenga, V;
Kityo, C;
Kekitiinwa, A;
... Denti, P; + view all
(2016)
The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children.
British Journal of Clinical Pharmacology
, 82
(1)
pp. 185-198.
10.1111/bcp.12934.
|
Bienczak, A;
Denti, P;
Cook, A;
Wiesner, L;
Mulenga, V;
Kityo, C;
Kekitiinwa, A;
... McIlleron, H; + view all
(2016)
Plasma efavirenz exposure, sex, and age predict virological response in HIV-infected African children.
JAIDS Journal of Acquired Immune Deficiency Syndromes
, 73
(2)
pp. 161-168.
10.1097/QAI.0000000000001032.
|
Bienczak, A;
Denti, P;
Cook, A;
Wiesner, L;
Mulenga, V;
Kityo, C;
Kekitiinwa, A;
... McIlleron, H; + view all
(2017)
Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets.
AIDS
, 31
(7)
pp. 905-915.
10.1097/QAD.0000000000001376.
|
Bollen, PDJ;
Moore, CL;
Mujuru, HA;
Makumbi, S;
Kekitiinwa, AR;
Kaudha, E;
Parker, A;
... ODYSSEY trial team, .; + view all
(2020)
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial.
The Lancet HIV
, 7
(8)
e533-e544.
10.1016/S2352-3018(20)30189-2.
|
Bourke, C;
Gough, E;
Pimundu, G;
Shonhai, A;
Berejena, C;
Terry, L;
Baumard, L;
... Prendergast, AJ; + view all
(2019)
Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation.
Science Translational Medicine
, 11
(486)
, Article eaav0537. 10.1126/scitranslmed.aav0537.
|
Butler, K;
Inshaw, J;
Ford, D;
Bernays, S;
Scott, K;
Kenny, J;
Klein, N;
... Gibb, D; + view all
(2016)
BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.
Health Technology Assessment
, 20
(49)
10.3310/hta20490.
|
Butler, K;
Turkova, A;
Inshaw, J;
Compagnucci, A;
Kenny, J;
Saidi, Y;
Musiime, V;
... Gibb, DM; + view all
(2016)
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial.
LANCET HIV
, 3
(9)
E421-E430.
10.1016/S2352-3018(16)30054-6.
|
Bwakura-Dangarembizi, M;
Kendall, L;
Bakeera-Kitaka, S;
Nahirya-Ntege, P;
Keishanyu, R;
Nathoo, K;
Spyer, MJ;
... Antiretroviral Research for Watoto (ARROW) Trial Team; + view all
(2014)
A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
New England Journal of Medicine
, 370
(1)
41 - 53.
10.1056/NEJMoa1214901.
|
Bwakura-Dangarembizi, M;
Musiime, V;
Szubert, AJ;
Prendergast, AJ;
Gomo, ZA;
Thomason, MJ;
Musarurwa, C;
... Nathoo, K; + view all
(2015)
Prevalence of Lipodystrophy and Metabolic Abnormalities in HIV-infected African Children after 3 Years on First-line Antiretroviral Therapy.
Pediatr Infect Dis J
, 34
(2)
e23 - e31.
10.1097/INF.0000000000000491.
|
Caby, F;
Guiguet, M;
Weiss, L;
Winston, A;
Miro, JM;
Konopnicki, D;
Le Moing, V;
... (CD4/CD8 ratio and cancer risk) project Working Group for the Co; + view all
(2021)
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
Clinical Infectious Diseases
, 73
(1)
pp. 50-59.
10.1093/cid/ciaa1137.
|
Cataldo, F;
Seeley, J;
Nkhata, MJ;
Mupambireyi, Z;
Tumwesige, E;
Gibb, DM;
Lablite Team;
(2018)
She knows that she will not come back: tracing patients and new thresholds of collective surveillance in PMTCT Option B+.
BMC Health Services Research
, 18
, Article 76. 10.1186/s12913-017-2826-7.
|
Chabala, Chishala;
Turkova, Anna;
Kapasa, Monica;
LeBeau, Kristen;
Tembo, Chimuka H;
Zimba, Kevin;
Weisner, Lubbe;
... SHINE trial team; + view all
(2023)
Inadequate Lopinavir Concentrations With Modified 8-hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV.
The Pediatric Infectious Disease Journal (PIDJ)
10.1097/INF.0000000000004047.
(In press).
|
Chabala, Chishala;
Wobudeya, Eric;
van der Zalm, Marieke M;
Kapasa, Monica;
Raichur, Priyanka;
Mboizi, Robert;
Palmer, Megan;
... SHINE trial team, .; + view all
(2024)
Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
Clinical Infectious Diseases
, Article ciae193. 10.1093/cid/ciae193.
(In press).
|
Chabala, C;
Turkova, A;
Thomason, MJ;
Wobudeya, E;
Hissar, S;
Mave, V;
van der Zalm, M;
... Gibb, DM; + view all
(2018)
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): A study protocol for a randomised controlled trial.
Trials
, 19
(1)
, Article 237. 10.1186/s13063-018-2608-5.
|
Chan, AK;
Ford, D;
Namata, H;
Muzambi, M;
Nkhata, MJ;
Abongomera, G;
Mambule, I;
... Lablite Team, ; + view all
(2014)
The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe.
BMC Health Services Research
, 14
, Article 352. 10.1186/1472-6963-14-352.
|
Chan, MK;
Goodall, R;
Judd, A;
Klein, N;
Chiappini, E;
Klimkait, T;
Ngo-Giang-Huong, N;
... Babiker, AGA; + view all
(2019)
Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand.
AIDS
, 33
(7)
pp. 1155-1165.
10.1097/QAD.0000000000002172.
|
Chandasana, Hardik;
Thapar, Mita;
Hayes, Siobhan;
Baker, Mark;
Gibb, Diana M;
Turkova, Anna;
Ford, Deborah;
... IMPAACT P1093, ODYSSEY (PENTA 20) Study Teams; + view all
(2023)
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents.
Clinical Pharmacokinetics
10.1007/s40262-023-01289-5.
(In press).
|
Chappell, E;
Kohns Vasconcelos, M;
Goodall, RL;
Galli, L;
Goetghebuer, T;
Noguera-Julian, A;
Rodrigues, LC;
... European Pregnancy and Paediatric Infections Cohort Collaboratio; + view all
(2021)
Children living with HIV in Europe: do migrants have worse treatment outcomes?
HIV Medicine
10.1111/hiv.13177.
(In press).
|
Chappell, Elizabeth;
Chimwaza, Anesu;
Manika, Ngoni;
Wedderburn, Catherine;
Mupambireyi Nenguke, Zivai;
Calder, Hannah;
Cowan, Frances;
... Bwakura-Dangarembizi, Mutsa; + view all
(2022)
Impact of the COVID-19 pandemic on the provision and uptake of services for the prevention of mother-to-child transmission of HIV in Zimbabwe.
PLOS Global Public Health
, 3
(8)
, Article e0002296. 10.1371/journal.pgph.0002296.
|
Chappell, E;
Group Authorship: The European Pregnancy and Paediatric Infectio;
(2021)
Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand.
AIDS
10.1097/QAD.0000000000002965.
(In press).
|
Charakida, M;
Donald, AE;
Green, H;
Storry, C;
Clapson, M;
Caslake, M;
Dunn, DT;
... Deanfield, JE; + view all
(2005)
Early structural and functional changes of the vasculature in HIV-infected children: Impact of disease and antiretroviral therapy.
Circulation
, 112
(1)
pp. 103-109.
10.1161/CIRCULATIONAHA.104.517144.
|
Chereau, F;
Madec, Y;
Sabin, C;
Obel, N;
Ruiz-Mateos, E;
Chrysos, G;
Fidler, S;
... HIV Controllers Project Working Group for the Collaboration of O; + view all
(2017)
Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.
PLoS One
, 12
(4)
, Article e0173893. 10.1371/journal.pone.0173893.
|
Childs, T;
Shingadia, D;
Goodall, R;
Doerholt, K;
Lyall, H;
Duong, T;
Judd, A;
... Collins, IJ; + view all
(2015)
Outcomes after viral load rebound on fi rst-line antiretroviraltreatment in children with HIV in the UK and Ireland:an observational cohort study.
Lancet HIV
, 2
(4)
e151-e158.
10.1016/S2352-3018(15)00021-1.
|
Chiwaula, LS;
Revill, P;
Ford, D;
Nkhata, M;
Mabugu, T;
Hakim, J;
Kityo, C;
... van den Berg, B; + view all
(2016)
Measuring and Valuing Informal Care for Economic Evaluation of HIV/AIDS Interventions: Methods and Application in Malawi.
Value in Health Regional Issues
, 10
pp. 73-78.
10.1016/j.vhri.2016.08.002.
|
Collins, I;
Wools-Kaloustian, K;
Goodall, R;
Smith, C;
Judd, A;
The Collaborative Initiative for Paediatric HIV Education and Re, .;
(2019)
Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.
The Lancet HIV
, 6
(2)
e105-e115.
10.1016/S2352-3018(18)30319-9.
|
Collins, IJ;
Foster, C;
Tostevin, A;
Tookey, P;
Riordan, A;
Dunn, D;
Gibb, DM;
(2017)
Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.
Clinical Infectious Diseases
, 64
(8)
pp. 1105-1112.
10.1093/cid/cix063.
|
Collins, IJ;
Judd, A;
Gibb, DM;
(2014)
Immediate antiretroviral therapy in young HIV-infected children: benefits and risks.
Curr Opin HIV AIDS
, 9
(1)
pp. 87-94.
10.1097/COH.0000000000000027.
|
Collins, J;
(2018)
Time to switch to second-line antiretroviral therapy in children with HIV in Europe and Thailand.
Clinical Infectious Diseases
, 66
(4)
pp. 594-603.
10.1093/cid/cix854.
|
Compagnucci, Alexandra;
Chan, Man K;
Saïdi, Yacine;
Cressey, Tim R;
Bamford, Alasdair;
Riault, Yoann;
Coelho, Alexandra;
... Sibanda, N; + view all
(2023)
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.
eClinicalMedicine
, 60
, Article 102025. 10.1016/j.eclinm.2023.102025.
|
Connon, R;
George, EC;
Olupot-Olupot, P;
Kiguli, S;
Chagaluka, G;
Alaroker, F;
Opoka, RO;
... TRACT trial group; + view all
(2021)
Incidence and predictors of hospital readmission in children presenting with severe anaemia in Uganda and Malawi: a secondary analysis of TRACT trial data.
BMC Public Health
, 21
(1)
, Article 1480. 10.1186/s12889-021-11481-6.
|
Copelyn, J;
Thompson, LC;
Le Prevost, M;
Castro, H;
Sturgeon, K;
Rowson, K;
Brice, S;
... Adolescents and Adults Living with Perinatal HIV (AALPHI) Steeri; + view all
(2019)
Self-harm in young people with perinatal HIV and HIV negative young people in England: cross sectional analysis.
BMC Public Health
, 19
(1)
, Article 1165. 10.1186/s12889-019-7424-7.
|
Crichton, S;
Belfrage, E;
Collins, IJ;
Doerholt, K;
Judd, A;
Le Coeur, S;
Spoulou, V;
... Group authorship: The European Pregnancy and Paediatric HIV Coho, .; + view all
(2019)
Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand.
AIDS
10.1097/QAD.0000000000002294.
(In press).
|
Crook, AM;
Turkova, A;
Musiime, V;
Bwakura-Dangarembizi, M;
Bakeera-Kitaka, S;
Nahirya-Ntege, P;
Thomason, M;
... ARROW Trial Team; + view all
(2016)
Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
BMC Medicine
, 14
(50)
pp. 1-11.
10.1186/s12916-016-0593-7.
|
Davies, M-A;
Gibb, D;
Turkova, A;
(2016)
Survival of HIV-1 vertically infected children.
Current Opinion in HIV and AIDS
, 11
(5)
pp. 455-464.
10.1097/COH.0000000000000303.
|
Dolling, DI;
Goodall, RL;
Chirara, M;
Hakim, J;
Nkurunziza, P;
Munderi, P;
Eram, D;
... DART Virology Group, .; + view all
(2017)
The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data.
BMC Infectious Diseases
, 17
(1)
, Article 160. 10.1186/s12879-017-2266-3.
|
Donovan, J;
Cresswell, FV;
Thuong, NTT;
Boulware, DR;
Thwaites, GE;
Bahr, NC;
Tuberculous Meningitis International Research Consortium, .;
(2020)
Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward.
Clinical Infectious Diseases
, 71
(8)
pp. 2002-2005.
10.1093/cid/ciaa473.
|
Donovan, J;
Rohlwink, UK;
Tucker, EW;
Hiep, NTT;
Thwaites, GE;
Figaji, AA;
Aarnoutse, RE;
... Wilkinson, RJ; + view all
(2020)
Checklists to guide the supportive and critical care of tuberculous meningitis.
Wellcome Open Research
, 4
, Article 163. 10.12688/wellcomeopenres.15512.2.
|
Donovan, J;
Rohlwink, UK;
Tucker, EW;
Hiep, NTT;
Thwaites, GE;
Figaji, AA;
Aarnoutse, RE;
... Wilkinson, RJ; + view all
(2019)
Checklists to guide the supportive and critical care of tuberculous meningitis [version 1; peer review: 2 approved].
Wellcome Open Research
, 4
, Article 163. 10.12688/wellcomeopenres.15512.1.
|
Duong, Trinh;
Brigden, Joanna;
Simon Schaaf, H;
Garden, Frances;
Marais, Ben J;
Anh Nguyen, Thu;
White, Ian R;
... Fox, Greg J; + view all
(2025)
A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis.
NEJM Evidence
, 4
(1)
10.1056/EVIDoa2400190.
|
Duong, T;
Judd, A;
Collins, IJ;
Doerholt, K;
Lyall, H;
Foster, C;
Butler, K;
... Gibb, DM; + view all
(2014)
Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland.
AIDS
, 28
(16)
2395 - 2405.
10.1097/QAD.0000000000000438.
|
EPPICC, CC;
Chappell, E;
Goodall, R;
Judd, A;
Gibb, D;
Collins, I;
(2020)
Prevalence and clinical outcomes of poor immune response despite virologically suppressive antiretroviral therapy among children and adolescents with HIV in Europe and Thailand: cohort study.
Clinical Infectious Diseases
, 70
(3)
pp. 404-415.
10.1093/cid/ciz253.
|
Farmer, R;
Daniel, R;
Ford, D;
Cook, A;
Musiime, V;
Bwakura-Dangarembizi, M;
Gibb, D;
... Walker, A; + view all
(2020)
Marginal Structural Models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy.
PLoS One
, 15
(7)
, Article e0233877. 10.1371/journal.pone.0233877.
|
Ferrand, RA;
Bandason, T;
Musvaire, P;
Larke, N;
Nathoo, K;
Mujuru, H;
Ndhlovu, CE;
... Corbett, EL; + view all
(2010)
Causes of Acute Hospitalization in Adolescence: Burden and Spectrum of HIV-Related Morbidity in a Country with an Early-Onset and Severe HIV Epidemic: A Prospective Survey.
PLOS Medecine
, 7
(2)
, Article e1000178. 10.1371/journal.pmed.1000178.
|
Fillekes, Q;
Kendall, L;
Kitaka, S;
Mugyenyi, P;
Musoke, P;
Ndigendawani, M;
Bwakura-Dangarembizi, M;
... ARROW Trial Team; + view all
(2014)
Pharmacokinetics of Zidovudine Dosed Twice Daily According to World Health Organization Weight Bands in Ugandan HIV-infected Children.
Pediatric Infectious Disease Journal
, 33
(5)
495 - 498.
10.1097/INF.0000000000000143.
|
Fillekes, Q;
Muro, EP;
Chunda, C;
Aitken, S;
Kisanga, ER;
Kankasa, C;
Thomason, MJ;
... Burger, DM; + view all
(2013)
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trial.
Journal of Antimicrobial Chemotherapy
, 68
(11)
pp. 2609-2615.
10.1093/jac/dkt246.
|
Fitzgerald, F;
Naveed, A;
Wing, K;
Gbessay, M;
Ross, JCG;
Checchi, F;
Youkee, D;
... Yeung, S; + view all
(2016)
Ebola virus disease in children, Sierra Leone, 2014–2015.
Emerging Infectious Diseases
, 22
(10)
pp. 1769-1777.
10.3201/eid2210.160579.
|
Fitzgerald, F;
Wing, K;
Naveed, A;
Gbessay, M;
Ross, JCG;
Checchi, F;
Youkee, D;
... Yeung, S; + view all
(2017)
Risk in the "Red Zone": outcomes for children admitted to Ebola holding units in Sierra Leone without Ebola virus disease.
Clinical Infectious Diseases
10.1093/cid/cix223.
(In press).
|
Fitzgerald, F;
Wing, K;
Naveed, A;
Gbessay, M;
Ross, JCG;
Checchi, F;
Youkee, D;
... Yeung, S; + view all
(2018)
Development of a pediatric ebola predictive score, Sierra Leone.
Emerging Infectious Diseases
, 24
(2)
pp. 311-319.
10.3201/eid2402.171018.
|
Fitzgerald, FC;
Lhomme, E;
Harris, K;
Kenny, J;
Doyle, R;
Kityo, C;
Shaw, LP;
... CHAPAS-3 Trial Team; + view all
(2019)
Microbial translocation does not drive immune activation in Ugandan children with HIV.
Journal of Infectious Diseases
, 219
(1)
pp. 89-100.
10.1093/infdis/jiy495.
|
Ford, D;
Muzambi, M;
Nkhata, MJ;
Abongomera, A;
Joseph, S;
Ndlovu, M;
Mabugu, T;
... Lablite Team, .; + view all
(2017)
Implementation of antiretroviral therapy for life in pregnant/breastfeeding HIV+ women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite Project experience.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 74
(5)
pp. 508-516.
10.1097/QAI.0000000000001267.
|
Ford, D;
Turner, R;
Turkova, A;
Penazzato, M;
Musiime, V;
Bwakura-Dangarembizi, M;
Violari, A;
... Gibb, DM; + view all
(2018)
Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV.
Journal of Acquired Immune Deficiency Syndromes
, 78
(Sup)
S40-S48.
10.1097/QAI.0000000000001748.
|
Ford, DJ;
Robins, J;
Petersen, M;
Gibb, DM;
Gilks, CF;
Mugyenyi, P;
Grosskurth, H;
... Walker, AS; + view all
(2015)
The impact of different CD4 monitoring and switching strategies on mortality in HIV-infected African adults on antiretroviral therapy; an application of dynamic marginal structural models.
American Journal of Epidemiology
, 182
(7)
10.1093/aje/kwv083.
|
Foster, C;
Judd, A;
Tookey, P;
Tudor-Williams, G;
Dunn, D;
Shingadia, D;
Butler, K;
... Collaborative HIV Paediat Study CH; + view all
(2009)
Young people in the United Kingdom and Ireland with perinatally acquired HIV: The pediatric legacy for adult services.
AIDS Patient Care and STDs
, 23
(3)
159 - 166.
10.1089/apc.2008.0153.
|
Francis, F;
Gough, EK;
Edens, TJ;
Berejena, C;
Bwakura-Dangarembizi, M;
Shonhai, A;
Nathoo, KJ;
... Manges, AR; + view all
(2020)
Cessation of long-term cotrimoxazole prophylaxis in HIV-infected children does not alter the carriage of antimicrobial resistance genes.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 85
(5)
pp. 801-605.
10.1097/QAI.0000000000002489.
|
Freguja, R;
Bamford, A;
Zanchetta, M;
Del Bianco, P;
Giaquinto, C;
Harper, L;
Dalzini, A;
... De Rossi, A; + view all
(2021)
Long‐term clinical, virological and immunological outcomes following planned treatment interruption in HIV‐infected children.
HIV Medicine
, 22
(3)
pp. 172-184.
10.1111/hiv.12986.
|
Freriksen, JJM;
van Seyen, M;
Judd, A;
Gibb, DM;
Collins, IJ;
Greupink, R;
Russel, FGM;
... Burger, DM; + view all
(2019)
Review article: Direct-acting antivirals for the treatment of HCV during pregnancy and lactation: implications for maternal dosing, foetal exposure, and safety for mother and child.
Alimentary Pharmacology and Therapeutics
10.1111/apt.15476.
(In press).
|
Frigati, Lisa Jane;
Gibb, Diana;
Harwell, Joseph;
Kose, Judith;
Musiime, Victor;
Rabie, Helena;
Rangaraj, Ajay;
... Penazzato, Martina; + view all
(2023)
The hard part we often forget: providing care to children and adolescents with advanced HIV disease.
Journal of the International AIDS Society
, 26
(3)
, Article e26041. 10.1002/jia2.26041.
|
Galileya, Lufina Tsirizani;
Wasmann, Roeland E;
Chabala, Chishala;
Rabie, Helena;
Lee, Janice;
Njahira Mukui, Irene;
Hesseling, Anneke;
... Denti, Paolo; + view all
(2023)
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.
PLoS Medicine
, 20
(11)
, Article e1004303. 10.1371/journal.pmed.1004303.
|
Galli, L;
Crichton, S;
Buzzoni, C;
Goetghebuer, T;
Jourdain, G;
Judd, A;
Klein, N;
... Goodall, R; + view all
(2019)
CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand.
HIV Medicine
10.1111/hiv.12745.
(In press).
|
George, EC;
Uyoga, S;
M'baya, B;
Kyeyune Byabazair, D;
Kiguli, S;
Olupot-Olupot, P;
Opoka, R;
... Maitland, K; + view all
(2022)
Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trial.
The Lancet Haematology
, 10
(1)
e360-e368.
10.1016/S2214-109X(21)00565-9.
|
George, E;
Kiguli, S;
Olupot Olupot, P;
Opoka, R;
Engoru, C;
Akech, S;
Nyeko, R;
... Walker, A; + view all
(2019)
Mortality risk over time after early fluid resuscitation in African children.
Critical Care
, 23
, Article 377. 10.1186/s13054-019-2619-y.
|
George, EC;
Walker, AS;
Kiguli, S;
Olupot-Olupot, P;
Opoka, RO;
Engoru, C;
Akech, SO;
... Babiker, AG; + view all
(2015)
Predicting mortality in sick African children: the FEAST Paediatric Emergency Triage (PET) Score.
BMC Medicine
, 13
, Article 174. 10.1186/s12916-015-0407-3.
|
Gibb, D;
(2021)
Plasticity of the Immune System in Children Following Treatment Interruption in HIV-1 Infection.
Frontiers in Immunology
, 12
, Article 643189. 10.3389/fimmu.2021.643189.
|
Gibb, D;
Wedderburn, C;
Groenewold, NA;
Roos, A;
Yeung, S;
Fouche, J-P;
Rehman, AM;
... Donald, KA; + view all
(2022)
Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort.
Journal of the International AIDS Society
, 25
(1)
, Article e25863. 10.1002/jia2.25863.
|
Gibb, Diana;
Wedderburn, Catherine;
Evans, Ceri;
Slogrove, Amy;
Rehman, Andrea;
Prendergast, Andrew;
Penazzato, Martina;
(2023)
Co-trimoxazole prophylaxis for children who are HIV-exposed and uninfected: a systematic review.
Journal of the International AIDS Society
, 26
(6)
, Article e26079. 10.1002/jia2.26079.
|
Gibb, DM;
Ford, D;
(2017)
Impact of decentralization of Antiretroviral Therapy services on HIV testing and care at population level in Agago District in rural Northern Uganda: Results from the Lablite population surveys.
International Health
, 9
(2)
pp. 91-99.
10.1093/inthealth/ihx006.
|
Gibb, DM;
Ford, D;
Seeley, J;
Hakim, J;
Gilks, C;
Kityoa, C;
Chan, A;
... Abongomera, G; + view all
(2018)
Patient level benefits associated with decentralisation of antiretroviral therapy services to primary health facilities in Malawi and Uganda.
International Health
, 10
(1)
pp. 8-19.
10.1093/inthealth/ihx061.
|
Gibb, DM;
Kizito, H;
Russell, EC;
Chidziva, E;
Zalwango, E;
Nalumenya, R;
Spyer, M;
... DART trial team, The; + view all
(2012)
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
PLoS Medicine
, 9
(5)
, Article e1001217. 10.1371/journal.pmed.1001217.
|
Gilks, CF;
Walker, AS;
Munderi, P;
Kityo, C;
Reid, A;
Katabira, E;
Goodall, RL;
... Team, DARTT; + view all
(2013)
Single CD4 Test with 250 Cells/Mm(3) Threshold Predicts Viral Suppression in HIV-Infected Adults Failing First-Line Therapy by Clinical Criteria.
PLOS ONE
, 8
(2)
, Article ARTN e57580. 10.1371/journal.pone.0057580.
|
Goodall, RL;
Dunn, DT;
Nkurunziza, P;
Mugarura, L;
Pattery, T;
Munderi, P;
Kityo, C;
... DART Virology Group; + view all
(2017)
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
Journal of Antimicrobial Chemotherapy
, 72
(5)
pp. 1450-1455.
10.1093/jac/dkw583.
|
Goodall, RL;
Dunn, DT;
Pattery, T;
van Cauwenberge, A;
Nkurunziza, P;
Awio, P;
Ndembi, N;
... DART Virology Group and Trial Teams; + view all
(2014)
Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda.
J Antimicrob Chemother
, 69
(7)
1938 - 1944.
10.1093/jac/dku052.
|
Gupta, RK;
Goodall, RL;
Ranopa, M;
Kityo, C;
Munderi, P;
Lyagoba, F;
Mugarura, L;
... DART Virology Group and Trial Team; + view all
(2014)
High Rate of HIV Re-suppression After Viral Failure on First Line Antiretroviral Therapy in the Absence of Switch to Second Line.
Clin Infect Dis
, 58
(7)
pp. 1023-1026.
10.1093/cid/cit933.
|
Haberer, JE;
Cook, A;
Walker, AS;
Ngambi, M;
Ferrier, A;
Mulenga, V;
Kityo, C;
... Bangsberg, DR; + view all
(2011)
Excellent Adherence to Antiretrovirals in HIV plus Zambian Children Is Compromised by Disrupted Routine, HIV Nondisclosure, and Paradoxical Income Effects.
PLOS ONE
, 6
(4)
, Article e18505. 10.1371/journal.pone.0018505.
|
Hachicha-Maalej, Nadia;
Lepers, Clotilde;
Collins, Intira Jeannie;
Mostafa, Aya;
Ades, Anthony E;
Judd, Ali;
Scott, Karen;
... Deuffic-Burban, Sylvie; + view all
(2024)
Modelling the potential clinical and economic impact of universal antenatal hepatitis C (HCV) screening and providing treatment for pregnant women with HCV and their infants in Egypt: a cost-effectiveness study.
BMJ Public Health
, 2
(1)
, Article e000517. 10.1136/bmjph-2023-000517.
|
Hakim, J;
Musiime, V;
Szubert, AJ;
Mallewa, J;
Siika, A;
Agutu, C;
Walker, S;
... Gibb, DM; + view all
(2017)
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.
New England Journal of Medicine
, 377
(3)
pp. 233-245.
10.1056/NEJMoa1615822.
|
Hesseling, AC;
Purchase, SE;
Martinson, NA;
Fairlie, L;
Schaaf, HS;
Brigden, J;
Staples, S;
... Seddon, JA; + view all
(2024)
Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis.
New England Journal of Medicine
, 391
(24)
pp. 2315-2326.
10.1056/NEJMoa2314318.
|
Houston, KA;
Gibb, J;
Olupot-Olupot, P;
Obonyo, N;
Mpoya, A;
Nakuya, M;
Muhindo, R;
... Maitland, K; + view all
(2019)
Gastroenteritis aggressive versus slow treatment for rehydration (GASTRO): a phase II rehydration trial for severe dehydration: WHO plan C versus slow rehydration.
BMC Medicine
, 17
(1)
, Article 122. 10.1186/s12916-019-1356-z.
|
Houston, KA;
Gibb, JG;
Mpoya, A;
Obonyo, N;
Olupot-Olupot, P;
Nakuya, M;
Evans, JA;
... Maitland, K; + view all
(2017)
Gastroenteritis Aggressive Versus Slow Treatment For Rehydration (GASTRO). A pilot rehydration study for severe dehydration: WHO plan C versus slower rehydration.
Wellcome Open Research
, 2
, Article 62. 10.12688/wellcomeopenres.12261.1.
|
Huynh, Julie;
Chabala, Chishala;
Sharma, Suvasini;
Choo, Louise;
Singh, Varinder;
Sankhyan, Naveen;
Mujuru, Hilda;
... Gibb, Diana M; + view all
(2025)
Effectiveness and safety of shortened intensive treatment for children with tuberculous meningitis (SURE): a protocol for a phase 3 randomised controlled trial evaluating 6 months of antituberculosis therapy and 8 weeks of aspirin in Asian and African children with tuberculous meningitis.
BMJ Open
, 15
(4)
, Article e088543. 10.1136/bmjopen-2024-088543.
|
Jacobs, Tom;
Waalewijn, Hylke;
Houlden, Lily;
Bollen, Pauline;
Nanduudu, Annet;
Nambi, Esether;
Cassim, Haseena;
... Colbers, Angela; + view all
(2024)
Influence of age and co-medication on dolutegravir glucuronidation in paediatric patients.
British Journal of Clinical Pharmacology
, Article e16238. 10.1111/bcp.16238.
(In press).
|
Judd, A;
Collins, IJ;
Pett, S;
Gibb, DM;
(2021)
Labour pains: eliminating HCV in women and children.
The Lancet Gastroenterology & Hepatology
, 6
(3)
pp. 150-151.
10.1016/S2468-1253(20)30373-3.
|
Judd, A;
Collins, IJ;
Parrott, F;
Hill, T;
Jose, S;
Ford, D;
Asad, H;
... Sabin, C; + view all
(2017)
Growing up with perinatal HIV: changes in clinical outcomes before and after transfer to adult care in the UK.
J Int AIDS Soc
, 20
(Suppl.3)
, Article 21577. 10.7448/IAS.20.4.21577.
|
Judd, A;
Foster, C;
Thompson, LC;
Sturgeon, K;
Le Prevost, M;
Jungmann, E;
Rowson, K;
... Adolescents and Adults Living with Perinatal HIV (AALPHI) Steeri; + view all
(2018)
Sexual health of young people with perinatal HIV and HIV negative young people in England.
PLOS One
, 13
(10)
, Article e0205597. 10.1371/journal.pone.0205597.
|
Judd, A;
Goodall, RL;
EPPICC Study Group, .;
(2018)
Long term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV in 17 middle- and high-income countries in Europe and Thailand: cohort study.
PLoS Medicine
, 15
(1)
, Article e1002491. 10.1371/journal.pmed.1002491.
|
Judd, A;
Le Prevost, M;
Melvin, D;
Arenas-Pinto, A;
Parrott, F;
Winston, A;
Foster, C;
... Adolescents and Adults Living With Perinatal HIV (AALPHI) Steeri, .; + view all
(2016)
Cognitive Function in Young Persons With and Without Perinatal HIV in the AALPHI Cohort in England: Role of Non-HIV-Related Factors.
Clinical Infectious Diseases
, 63
(10)
pp. 1380-1387.
10.1093/cid/ciw568.
|
Judd, A;
Lodwick, R;
Noguera-Julian, A;
Gibb, DM;
Butler, K;
Costagliola, D;
Sabin, C;
... Pursuing Later Treatment Options II Project Team, .; + view all
(2016)
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
HIV Medicine
10.1111/hiv.12411.
(In press).
|
Judd, A;
Melvin, D;
Thompson, LC;
Foster, C;
Le Prevost, M;
Evangeli, M;
Winston, A;
... Castro, H; + view all
(2020)
Factors Associated With Nonadherence to Antiretroviral Therapy Among Young People Living With Perinatally Acquired HIV in England.
The Journal of the Association of Nurses in AIDS Care (JANAC)
, 31
(5)
pp. 574-586.
10.1097/JNC.0000000000000171.
|
Katongole, F;
Arumugam, T;
Jennings, A;
Mutata, C;
Ssebunya, P;
Wamboi, C;
Green, A;
... Kabasingo, R; + view all
(2025)
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa.
Contemporary Clinical Trials
, 155
, Article 107963. 10.1016/j.cct.2025.107963.
(In press).
|
Kekitiinwa, A;
Musiime, V;
Thomason, MJ;
Mirembe, G;
Lallement, M;
Nakalanzi, S;
Baptiste, D;
... Judd, A; + view all
(2016)
Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children.
Antiviral Therapy
, 21
(7)
pp. 579-585.
10.3851/IMP3054.
|
Kekitiinwa, A;
Szubert, AJ;
Spyer, M;
Katuramu, R;
Musiime, V;
Mhute, T;
Bakeera-Kitaka, S;
... ARROW Trial Team, .; + view all
(2017)
Virologic Response to First-Line Efavirenz- or Nevirapine-Based Anti-Retroviral Therapy in HIV-Infected African Children.
Pediatric Infectious Disease Journal
, 36
(6)
pp. 588-594.
10.1097/INF.0000000000001505.
|
Kenny, J;
Doerholt, K;
Gibb, DM;
Judd, A;
Collaborative HIV Paediatric Study (CHIPS) Steering Committee, .;
(2017)
Who Gets Severe Gynecomastia Among HIV-Infected Children In The UK And Ireland?
Pediatric Infectious Disease Journal
, 36
(3)
pp. 307-310.
10.1097/INF.0000000000001424.
|
Kiguli, S;
Akech, SO;
Mtove, G;
Opoka, RO;
Engoru, C;
Olupot-Olupot, P;
Nyeko, R;
... Maitland, K; + view all
(2014)
WHO guidelines on fluid resuscitation in children: missing the FEAST data.
BMJ
, 348
, Article f7003. 10.1136/bmj.f7003.
|
Kityo, C;
Szubert, A;
Siika, A;
Heyderman, R;
Bwakura-Dangarembizi, M;
Lugemwa, A;
Mwaringa, S;
... Pett, S; + view all
(2018)
Raltegravir-intensified initial antiretroviral therapy in advanced HIV in Africa: a randomized controlled trial.
PLoS Medicine
, 15
(12)
, Article e1002706. 10.1371/journal..
|
Kiwuwa-Muyingo, S;
Abongomera, G;
Mambule, I;
Senjovu, D;
Katabira, E;
Kityo, C;
Gibb, DM;
... Seeley, J; + view all
(2019)
Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.
International Health
, 12
(5)
pp. 429-443.
10.1093/inthealth/ihz090.
|
Kiwuwa-Muyingo, S;
Oja, H;
Walker, AS;
Ilmonen, P;
Levin, J;
Mambule, I;
Reid, A;
... DART Trial Team, The; + view all
(2013)
Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.
BMC Infectious Diseases
, 13
, Article 395. 10.1186/1471-2334-13-395.
|
Klein, N;
Sefe, D;
Mosconi, I;
Zanchetta, M;
Castro, H;
Jacobsen, M;
Jones, H;
... Paediatric European Network for Treatment of AIDS (PENTA) 11 Tri, The; + view all
(2013)
The Immunological and Virological Consequences of Planned Treatment Interruptions in Children with HIV Infection.
PLoS One
, 8
(10)
, Article e76582. 10.1371/journal.pone.0076582.
|
Lara, AM;
Kigozi, J;
Amurwon, J;
Muchabaiwa, L;
Wakaholi, BN;
Mota, REM;
Walker, AS;
... Team, DARTT; + view all
(2012)
Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe.
PLoS One
, 7
(4)
, Article e33672. 10.1371/journal.pone.0033672.
|
Laughton, B;
Cornell, M;
Kidd, M;
Springer, PE;
Dobbels, EFM-T;
Rensburg, AJV;
Otwombe, K;
... Cotton, MF; + view all
(2018)
Five year neurodevelopment outcomes of perinatally HIV-infected children on early limited or deferred continuous antiretroviral therapy.
J Int AIDS Soc
, 21
(5)
, Article e25106. 10.1002/jia2.25106.
|
Le Prevost, M;
Judd, A;
Crichton, S;
Foster, C;
Bamford, A;
Ford, D;
Gibb, D;
... Driver, B; + view all
(2024)
Factors associated with engagement in HIV care for young people living with perinatally acquired HIV in England: An exploratory observational cohort study.
PLoS ONE
, 19
(5)
, Article e0302601. 10.1371/journal.pone.0302601.
|
Le Prevost, M;
Arenas-Pinto, A;
Melvin, D;
Parrott, F;
Foster, C;
Ford, D;
Evangeli, M;
... AALPHI Steering Committee, .; + view all
(2018)
Anxiety and depression symptoms in young people with perinatally acquired HIV and HIV affected young people in England.
AIDS Care
, 30
(8)
pp. 1040-1049.
10.1080/09540121.2018.1441972.
|
Lewis, J;
Payne, H;
Walker, AS;
Otwombe, K;
Gibb, DM;
Babiker, AG;
Panchia, R;
... Callard, RE; + view all
(2017)
Thymic output and CD4 T-cell reconstitution in HIV-infected children on early and interrupted antiretroviral treatment: evidence from the CHER trial.
Frontiers in Immunology
, 8
, Article 1162. 10.3389/fimmu.2017.01162.
|
Lyttle, MD;
Bielicki, J;
Barratt, S;
Dunn, D;
Finn, A;
Harper, L;
Jackson, P;
... Sharland, M; + view all
(2019)
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
BMJ Open
, 9
(5)
, Article e029875. 10.1136/bmjopen-2019-029875.
|
Maitland, K;
Obonyo, N;
Hamaluba, M;
Ogoda, E;
Mogaka, C;
Williams, TN;
Newton, C;
... George, EC; + view all
(2024)
A Phase I trial of Non-invasive Ventilation and seizure prophylaxis with levetiracetam In Children with Cerebral Malaria Trial (NOVICE-M Trial)
[version 1; peer review: 2 approved].
Wellcome Open Research
, 9
, Article 281. 10.12688/wellcomeopenres.21403.1.
|
Maitland, Kathryn;
Hamaluba, Mainga;
Obonyo, Nchafatso;
Oguda, Emmanuel;
Mogoka, Christabel;
Williams, Thomas N;
Chaponda, Mike;
... Severe Malaria in African Children A Research and Trials (SMAART; + view all
(2024)
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).
Wellcome Open Research
, 8
p. 484.
10.12688/wellcomeopenres.20111.2.
|
Maitland, Kathryn;
Ouattara, San Maurice;
Sainna, Hadiza;
Chara, Abdullahi;
Ogundipe, Oluwakemi F;
Sunyoto, Temmy;
Hamaluba, M;
... GASTROSAM Trial, Group; + view all
(2025)
Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis.
The New England Journal of Medicine
10.1056/NEJMoa2505752.
(In press).
|
Maitland, K;
George, EC;
Evans, JA;
Kiguli, S;
Olupot-Olupot, P;
Akech, SO;
Opoka, RO;
... Gibb, DM; + view all
(2013)
Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial.
BMC Medicine
, 11
, Article 68. 10.1186/1741-7015-11-68.
|
Maitland, K;
Kiguli, S;
Olupot-Olupot, P;
Engoru, C;
Mallewa, M;
Goncalves, PS;
Opoka, RO;
... Walker, AS; + view all
(2019)
Immediate Transfusion in African Children with Uncomplicated Severe Anemia.
New England Journal Of Medicine
, 381
(5)
pp. 407-419.
10.1056/NEJMoa1900105.
|
Maitland, K;
Kiguli, S;
Olupot-Olupot, P;
Opoka, RO;
Chimalizeni, Y;
Alaroker, F;
Uyoga, S;
... George, EC; + view all
(2021)
Transfusion management of severe anaemia in African children: a consensus algorithm.
British Journal of Haematology
10.1111/bjh.17429.
(In press).
|
Maitland, K;
Olupot-Olupot, P;
Kiguli, S;
Chagaluka, G;
Alaroker, F;
Opoka, RO;
Mpoya, A;
... Walker, AS; + view all
(2019)
Transfusion Volume for Children with Severe Anemia in Africa.
New England Journal Of Medicine
, 381
pp. 420-431.
10.1056/NEJMoa1900100.
|
Maitland, K;
Olupot-Olupot, P;
Kiguli, S;
Chagaluka, G;
Alaroker, F;
Opoka, RO;
Mpoya, A;
... Walker, A; + view all
(2019)
Co-trimoxazole or multivitamin multimineral supplement for post-discharge outcomes after severe anaemia in African children: a randomised controlled trial.
The Lancet Global Health
, 7
(10)
e1435-e1447.
10.1016/S2214-109X(19)30345-6.
|
Maitre, Thomas;
Bonnet, Maryline;
Calmy, Alexandra;
Raberahona, Mihaja;
Rakotoarivelo, Rivonirina Andry;
Rakotosamimanana, Niaina;
Ambrosioni, Juan;
... Bonnet, Fabrice; + view all
(2022)
Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial.
Trials
, 23
(1)
, Article 928. 10.1186/s13063-022-06772-1.
|
Makumbi, Shafic;
Bajunirwe, Francis;
Ford, Deborah;
Turkova, Anna;
South, Annabelle;
Lugemwa, Abbas;
Musiime, Victor;
... Tamwesigire, Imelda K; + view all
(2024)
Voluntariness of consent in paediatric HIV clinical trials: a mixed-methods, cross-sectional study of participants in the CHAPAS-4 and ODYSSEY trials in Uganda.
BMJ Open
, 14
(3)
, Article e077546. 10.1136/bmjopen-2023-077546.
|
Mallewa, J;
Szubert, AJ;
Mugyenyi, P;
Chidziva, E;
Thomason, MJ;
Chepkorir, P;
Abongomera, G;
... REALITY trial team, .; + view all
(2018)
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial.
The Lancet HIV
, 5
(5)
e231-e240.
10.1016/S2352-3018(18)30038-9.
|
Marais, S;
Van Toorn, R;
Chow, FC;
Manesh, A;
Siddiqi, OK;
Figaji, A;
Schoeman, JF;
... Wilkinson, RJ; + view all
(2020)
Management of intracranial tuberculous mass lesions: how long should we treat for? [version 3; peer review: 3 approved].
Wellcome Open Research
, 4
, Article 158. 10.12688/wellcomeopenres.15501.3.
|
Marais, S;
Van Toorn, R;
Chow, FC;
Manesh, A;
Siddiqi, OK;
Figaji, A;
Schoeman, JF;
... Wilkinson, RJ; + view all
(2019)
Management of intracranial tuberculous mass lesions: How long should we treat for? [version 2; peer review: 1 approved, 2 approved with reservations].
Wellcome Open Research
, 4
, Article 158. 10.12688/wellcomeopenres.15501.1.
|
Mathur, Shrey;
Smuk, Melanie;
Evans, Ceri;
Wedderburn, Catherine J;
Gibb, Diana M;
Penazzato, Martina;
Prendergast, Andrew J;
(2024)
Estimating the impact of alternative programmatic cotrimoxazole strategies on mortality among children born to mothers with HIV: A modelling study.
PLOS Medicine
, 21
(2)
, Article e1004334. 10.1371/journal.pmed.1004334.
(In press).
|
Migrant Health Working Group for the Collaboration of Observatio, .;
(2018)
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
HIV Medicine
, 19
(1)
pp. 42-48.
10.1111/hiv.12536.
|
Misra, UK;
Kalita, J;
Aarnoutse, RE;
Anderson, STB;
Bahr, NC;
Bang, ND;
Boulware, DR;
... Wilkinson, RJ; + view all
(2019)
Mechanism, spectrum, consequences and management of hyponatremia in tuberculous meningitis.
Wellcome Open Research
, 4
, Article 189. 10.12688/wellcomeopenres.15502.1.
|
Mocroft, A;
Lundgren, JD;
Sabin, ML;
Monforte, AD;
Brockmeyer, N;
Casabona, J;
Castagna, A;
... Collaboration of Observational HIV Epidemiological Research Euro; + view all
(2013)
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
PLoS Med
, 10
(9)
, Article e1001510. 10.1371/journal.pmed.1001510.
|
Moore, C;
Turkova, A;
Mujuru, H;
Kekitiinwa, A;
Lugemwa, A;
Kityo, C;
Barlow-Mosha, L;
... ODYSSEY Trial Team; + view all
(2021)
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.
BMC Infectious Diseases
, 21
, Article 5. 10.1186/s12879-020-05672-6.
|
Mpoya, A;
Kiguli, S;
Olupot-Olupot, P;
Opoka, RO;
Engoru, C;
Mallewa, M;
Chimalizeni, Y;
... Maitland, K; + view all
(2015)
Transfusion and Treatment of severe anaemia in African children (TRACT): a study protocol for a randomised controlled trial.
Trials
, 16
(593)
10.1186/s13063-015-1112-4.
|
Mramba, L;
Ngari, M;
Mwangome, M;
Muchai, L;
Bauni, E;
Walker, AS;
Gibb, DM;
... Berkley, JA; + view all
(2017)
A Growth Reference for Mid Upper Arm Circumference for Age among School Age Children and Adolescents, with Validation for Mortality in Two Cohorts.
BMJ
, 358
10.1136/bmj.j3423.
|
Mulenga, V;
Musiime, V;
Kekitiinwa, A;
Cook, AD;
Abongomera, G;
Kenny, J;
Chabala, C;
... CHAPAS-3 trial team, .; + view all
(2015)
Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.
Lancet Infectious Diseases
, 16
pp. 169-179.
10.1016/S1473-3099(15)00319-9.
|
Musiime, V;
Kasirye, P;
Naidoo-James, B;
Nahirya-Ntege, P;
Mhute, T;
Cook, A;
Mugarura, L;
... Walker, AS; + view all
(2016)
Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial.
AIDS
, 30
(11)
pp. 1761-1770.
10.1097/QAD.0000000000001116.
|
Musoke, P;
Szubert, AJ;
Musiime, V;
Nathoo, K;
Nahirya-Ntege, P;
Mutasa, K;
Williams, DE;
... Gibb, DM; + view all
(2015)
Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years.
AIDS
, 29
(13)
pp. 1623-1632.
10.1097/QAD.0000000000000749.
|
Natukunda, Eva;
Szubert, Alex;
Otike, Caroline;
Namyalo, Imerida;
Nambi, Esther;
Bamford, Alasdair;
Doerholt, Katja;
... Musoke, Phillipa; + view all
(2023)
Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
PLoS One
, 18
(7)
, Article e0288877. 10.1371/journal.pone.0288877.
|
Ngo-Giang-Huong, N;
Wittkop, L;
Judd, A;
Reiss, P;
Goetghebuer, T;
Duiculescu, D;
Noguera-Julian, A;
... EuroCoord-CHAIN-EPPICC joint project study group, .; + view all
(2016)
Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.
BMC Infectious Diseases
, 16
(1)
p. 654.
10.1186/s12879-016-1968-2.
|
Nkhata, MJ;
Muzambi, M;
Ford, D;
Chan, AK;
Abongomera, G;
Namata, H;
Mambule, I;
... Lablite team, .; + view all
(2016)
Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study.
BMC Health Services Research
, 16
, Article 660. 10.1186/s12913-016-1891-7.
|
Olupot-Olupot, Peter;
Aloroker, Florence;
Mpoya, Ayub;
Mnjalla, Hellen;
Paasi, George;
Nakuya, Margaret;
Houston, Kirsty;
... Maitland, Kathryn; + view all
(2024)
Gastroenteritis Rehydration Of children with Severe Acute Malnutrition (GASTROSAM): A Phase II Randomised Controlled trial: Trial Protocol [version 2; peer review: 2 approved].
Wellcome Open Research
, 6
p. 160.
10.12688/wellcomeopenres.16885.2.
|
Olupot-Olupot, Peter;
Okiror, William;
Mnjalla, Hellen;
Muhindo, Rita;
Uyoga, Sophie;
Mpoya, Ayub;
Williams, Thomas N;
... Maitland, Kathryn; + view all
(2023)
Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a protocol for a Phase II randomised controlled trial [version 2; peer review: 1 approved with reservations].
Wellcome Open Research
, 6
p. 161.
10.12688/wellcomeopenres.16968.2.
|
Olupot-Olupot, P;
Aloroker, F;
Mpoya, A;
Mnjalla, H;
Passi, G;
Nakuya, M;
Houston, K;
... Maitland, K; + view all
(2021)
Gastroenteritis Rehydration Of children with Severe Acute Malnutrition (GASTROSAM): A Phase II Randomised Controlled trial: Trial Protocol [version 1; peer review: 1 approved].
Wellcome Open Research
, 6
, Article 160. 10.12688/wellcomeopenres.16885.1.
|
Olupot-Olupot, P;
Engoru, C;
Uyoga, S;
Muhindo, R;
Macharia, A;
Kiguli, S;
Opoka, RO;
... Maitland, K; + view all
(2017)
High Frequency of Blackwater Fever Among Children Presenting to Hospital With Severe Febrile Illnesses in Eastern Uganda.
Clinical Infectious Diseases
, 64
(7)
pp. 939-946.
10.1093/cid/cix003.
|
Olupot-Olupot, P;
Okiror, W;
Mnjalla, H;
Muhindo, R;
Uyoga, S;
Mpoya, A;
Williams, TN;
... Maitland, K; + view all
(2021)
Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a protocol for a Phase II randomised controlled trial [version 1; peer review: awaiting peer review].
Wellcome Open Research
, 6
, Article 161. 10.12688/wellcomeopenres.16968.1.
|
Patel, K;
Smith, C;
Collins, IJ;
Goodall, R;
Abrams, EJ;
Sohn, AH;
Mohamed, TJ;
... Nuwagaba, H; + view all
(2020)
Outcomes of second‐line antiretroviral therapy among children living with HIV: a global cohort analysis.
Journal of the International AIDS Society
, 23
(4)
, Article e25477. 10.1002/jia2.25477.
|
Payne, H;
Chan, MK;
Watters, SA;
Otwombe, K;
Hsiao, N-Y;
Babiker, A;
Violari, A;
... Klein, NJ; + view all
(2021)
Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial.
AIDS Research and Therapy
, 18
, Article 63. 10.1186/s12981-021-00389-1.
|
Payne, H;
Chain, G;
Adams, S;
Hunter, P;
Luckhurst, N;
Gilmour, K;
Lewis, J;
... Klein, N; + view all
(2019)
Naïve B-cell Output in Hiv-infected and Hiv-uninfected Children.
AIDS Research and Human Retroviruses
, 35
(1)
10.1089/AID.2018.0170.
|
Payne, H;
Lawrie, D;
Nieuwoudt, M;
Cotton, M;
Gibb, D;
Babiker, A;
Glencross, D;
(2020)
Comparison of lymphocyte subset populations in children from South Africa, US and Europe.
Frontiers in Pediatrics
, 8
, Article 406. 10.3389/fped.2020.00406.
|
Pediatric AIDS-Defining Cancer Project Working Group for IeDEA S, .;
(2016)
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
Clinical Infectious Diseases
, 63
(9)
pp. 1245-1253.
10.1093/cid/ciw519.
|
Penazzato, M;
Gnanashanmugam, D;
Rojo, P;
Lallemant, M;
Lewis, LL;
Rocchi, F;
Saint Raymond, A;
... Abrams, EJ; + view all
(2017)
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations.
Clinical Infectious Diseases
, 64
(11)
pp. 1597-1603.
10.1093/cid/cix194.
|
Pett, SL;
Spyer, M;
Haddow, L;
Nhema, R;
Benjamin, L;
Najjuka, G;
Bilima, S;
... Walker, A; + view all
(2021)
Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.
AIDS
, 35
(4)
pp. 585-594.
10.1097/QAD.0000000000002781.
|
Picat, MQ;
Lewis, J;
Musiime, V;
Prendergast, A;
Nathoo, K;
Kekitiinwa, A;
Nahirya Ntege, P;
... ARROW Trial Team, The; + view all
(2013)
Predicting Patterns of Long-Term CD4 Reconstitution in HIV-Infected Children Starting Antiretroviral Therapy in Sub-Saharan Africa: A Cohort-Based Modelling Study.
PLoS Med
, 10
(10)
, Article e1001542. 10.1371/journal.pmed.1001542.
|
Post, FA;
Szubert, AJ;
Prendergast, AJ;
Johnston, V;
Lyall, H;
Fitzgerald, F;
Musiime, V;
... Pett, SL; + view all
(2018)
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
Clinical Infectious Diseases
, 66
(S2)
S132-S139.
10.1093/cid/cix1141.
|
Prendergast, A;
Szubert, A;
Berejena, C;
Pimundu, G;
Pala, P;
Shonhai, A;
Musiime, V;
... Klein, N; + view all
(2016)
Baseline inflammatory biomarkers identify subgroups of HIV-infected African children with differing responses to antiretroviral therapy.
Journal of Infectious Diseases
, 214
(2)
pp. 226-236.
10.1093/infdis/jiw148.
|
Prendergast, AJ;
Berejena, C;
Pimundu, G;
Shonhai, A;
Bwakura-Dangarembizi, M;
Musiime, V;
Szubert, AJ;
... Walker, AS; + view all
(2019)
Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe.
AIDS
, 33
(9)
pp. 1485-1490.
10.1097/QAD.0000000000002231.
|
Prendergast, AJ;
Bwakura-Dangarembizi, M;
Mugyenyi, P;
Lutaakome, J;
Kekitiinwa, A;
Thomason, MJ;
Gibb, DM;
(2016)
Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.
AIDS
, 30
(18)
pp. 2823-2829.
10.1097/QAD.0000000000001264.
|
Prendergast, AJ;
Penazzato, M;
Gibb, DM;
Cotton, M;
Musoke, P;
Mulenga, V;
Abrams, EJ;
(2012)
Treatment of young children with HIV infection: Using evidence to inform policymakers.
PLoS Medicine
, 9
(7)
, Article e1001273. 10.1371/journal.pmed.1001273.
|
Prendergast, AJ;
Szubert, AJ;
Pimundu, G;
Berejena, C;
Pala, P;
Shonhai, A;
Hunter, P;
... Klein, N; + view all
(2021)
The impact of viraemia on inflammatory biomarkers and CD4 cell subpopulations in HIV-infected children in sub-Saharan Africa.
AIDS
, 35
(10)
pp. 1537-1548.
10.1097/QAD.0000000000002916.
(In press).
|
Prendergast, AJ;
Szubert, AJ;
Spyer, MJ;
Musiime, V;
Musoke, P;
Bwakura-Dangarembizi, M;
Nahirya-Ntege, P;
... Walker, AS; + view all
(2017)
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
PLOS Medicine
, 14
(11)
, Article e1002432. 10.1371/journal.pmed.1002432.
|
Revill, PA;
Walker, S;
Mabugu, T;
Nathoo, KJ;
Mugyenyi, P;
Kekitinwa, A;
Munderi, P;
... Gibb, DM; + view all
(2015)
Opportunities for improving the efficiency of paediatric HIV treatment programmes.
AIDS
, 29
(2)
201 - 210.
10.1097/QAD.0000000000000518.
|
Revill, PA;
Walker, S;
Sculpher, MJ;
Mabugu, T;
Nathoo, KJ;
Bwakura-Dangarembizi, M;
Mugyenyi, P;
... Gibb, DM; + view all
(2015)
Opportunities for improving the efficiency of paediatric HIV treatment programmes.
AIDS
, 29
(2)
201 - 210.
10.1097/QAD.0000000000000518.
|
|
Roland, Damian;
Stohr, Wolfgang;
Gibb, Diana;
Sturgeon, Kate;
Bielicki, Julia Anna;
Lyttle, Mark D;
(2025)
Evidence of Poor Utility of Current Sepsis Screening Tools in an At-Risk Population of Children With Community-Acquired Pneumonia.
Pediatric Infectious Disease Journal
10.1097/inf.0000000000004758.
(In press).
|
Ross, LL;
Walker, AS;
Lou, Y;
Tenorio, AR;
Gibb, DM;
Double, J;
Gilks, C;
... Shaefer, MS; + view all
(2019)
Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min.
PLoS One
, 14
(11)
, Article e0225199. 10.1371/journal.pone.0225199.
|
Seddon, JA;
Garcia-Prats, AJ;
Purchase, SE;
Osman, M;
Demers, A-M;
Hoddinott, G;
Crook, AM;
... Hesseling, AC; + view all
(2019)
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).
Trials
(In press).
|
Seddon, JA;
Thwaites, GE;
Aarnoutse, RE;
Anderson, STB;
Bahr, NC;
Bang, ND;
Boulware, DR;
... Wilkinson, RJ; + view all
(2019)
Tuberculous meningitis: new tools and new approaches required [version 1; peer review: not peer reviewed].
Wellcome Open Research
, 4
, Article 181. 10.12688/wellcomeopenres.15591.1.
|
Seddon, JA;
Tugume, L;
Solomons, R;
Prasad, K;
Bahr, NC;
Aarnoutse, RE;
Anderson, STB;
... Wilkinson, RJ; + view all
(2019)
The current global situation for tuberculous meningitis: Epidemiology, diagnostics, treatment and outcomes.
Wellcome Open Research
, 4
, Article 167. 10.12688/wellcomeopenres.15535.1.
|
Seddon, JA;
Wilkinson, R;
van Crevel, R;
Figaji, A;
Thwaites, GE;
Aarnoutse, RE;
Anderson, STB;
... Wilkinson, RJ; + view all
(2019)
Knowledge gaps and research priorities in tuberculous meningitis [version 1; peer review: 3 approved].
Wellcome Open Research
, 4
, Article 188. 10.12688/wellcomeopenres.15573.1.
|
Siika, A;
McCabe, L;
Bwakura-Dangarembizi, M;
Kityo, C;
Mallewa, J;
Berkley, J;
Maitland, K;
... Gibb, DM; + view all
(2018)
Late presentation with HIV in Africa: phenotypes, risk and risk stratification in the REALITY trial.
Clinical Infectious Diseases
, 66
(S2)
S140-S146.
10.1093/cid/cix1142.
|
Ssengooba, W;
de Dieu Iragena, J;
Nakiyingi, L;
Mujumbi, S;
Wobudeya, E;
Mboizi, R;
Boulware, D;
... Gibb, DM; + view all
(2020)
Accuracy of Xpert Ultra in the diagnosis of pulmonary tuberculosis among children in Uganda: a sub-study from the SHINE trial.
Journal of Clinical Microbiology
, 58
(9)
, Article e00410-20. 10.1128/JCM.00410-20.
|
Sturgeon, Kate;
Judd, Ali;
Burke, Tom;
Foster, Caroline;
Gibb, Diana M;
Le Prevost, Marthe;
Mhizha, Warren;
(2024)
Disseminating the research findings from the adolescents and adults living with Perinatal HIV (AALPHI) study: an approach from young people living with HIV.
Research Involvement and Engagement
, 10
, Article 9. 10.1186/s40900-024-00541-x.
|
Sturgeon, K;
Castro, H;
Le Prevost, M;
Thompson, L;
Chappell, E;
Foster, C;
Rowson, K;
... Judd, A; + view all
(2020)
Experiences of transition to adult care and readiness to self-manage care in young people with perinatal HIV in England.
HIV Nursing
, 20
(1)
pp. 8-14.
|
Sutherland, KA;
Goodall, RL;
McCormick, A;
Kapaata, A;
Lyagoba, F;
Kaleebu, P;
Thiltgen, G;
... DART Trial Team; + view all
(2015)
Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa.
AIDS Research and Human Retroviruses
, 31
(10)
pp. 1032-1037.
10.1089/aid.2015.0138.
|
Sutherland, KA;
Parry, CM;
McCormick, A;
Kapaata, A;
Lyagoba, F;
Kaleebu, P;
Gilks, CF;
... DART Virology Group, .; + view all
(2015)
Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
PLoS One
, 10
(9)
, Article e0137834. 10.1371/journal.pone.0137834.
|
Szubert, AJ;
Musiime, V;
Bwakura-Dangarembizi, M;
Nahirya-Ntege, P;
Kekitiinwa, A;
Gibb, DM;
Nathoo, K;
... ARROW Trial Team, ; + view all
(2015)
Pubertal development in HIV-infected African children on first-line antiretroviral therapy.
AIDS
, 29
(5)
609 - 618.
10.1097/QAD.0000000000000590.
|
Tagarro, A;
Chan, M;
Zangari, P;
Ferns, B;
Foster, C;
De Rossi, A;
Nastouli, E;
... EPIICAL Consortium, .; + view all
(2018)
Early and Highly Suppressive ART are Main Factors Associated with Low Viral Reservoir in European Perinatally HIV Infected Children.
Journal of Acquired Immune Deficiency Syndromes (JAIDS)
, 79
(2)
pp. 269-276.
10.1097/QAI.0000000000001789.
|
Tenforde, MW;
Walker, AS;
Gibb, DM;
Manabe, YC;
(2019)
Rapid antiretroviral therapy initiation in low and middle-income countries: A resource-based approach.
PLoS Medicine
, 16
(1)
, Article e1002723. 10.1371/journal.pmed.1002723.
|
The Collaborative Initiative for Paediatric HIV Education and Re, .;
Slogrove, AL;
Schomaker, M;
Davies, M-A;
Williams, P;
Balkan, S;
Ben-Farhat, J;
... Leroy, V; + view all
(2018)
The epidemiology of adolescents living with perinatally-acquired HIV: a cross-region global cohort analysis.
PLoS Medicine
, 15
(3)
, Article e1002514. 10.1371/journal.pmed.1002514.
|
Tierrablanca, LE;
Ochalek, J;
Ford, D;
Babiker, A;
Gibb, D;
Butler, K;
Turkova, A;
... BREATHER (PENTA 16) Trial Group; + view all
(2018)
Economic evaluation of weekends-off antiretroviral therapy for young people in 11 countries.
Medicine
, 97
(5)
, Article e9698. 10.1097/MD.0000000000009698.
|
Tikiso, T;
McIlleron, H;
Burger, D;
Gibb, D;
Rabie, H;
Lee, J;
Lallemant, M;
... Denti, P; + view all
(2022)
Abacavir pharmacokinetics in African children living with HIV: A pooled analysis describing the effects of age, malnutrition and common concomitant medications.
British Journal of Clinical Pharmacology
, 88
(2)
pp. 403-415.
10.1111/bcp.14984.
|
Turkova, A;
White, E;
Mujuru, HA;
Kekitiinwa, AR;
Kityo, CM;
Violari, A;
Lugemwa, A;
... ODYSSEY Trial Team; + view all
(2021)
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
The New England Journal of Medicine
, 385
(27)
pp. 2531-2543.
10.1056/NEJMoa2108793.
|
Turkova, Anna;
Palmer, Megan;
Gibb, Diana M;
(2022)
Shorter Treatment for Tuberculosis in Children. Reply.
New England Journal of Medicine
, 386
(25)
pp. 2439-2440.
10.1056/NEJMc2204561.
|
Turkova, Anna;
Waalewijn, Hylke;
Chan, Man K;
Bollen, Pauline DJ;
Bwakura-Dangarembizi, Mutsa F;
Kekitiinwa, Adeodata R;
Cotton, Mark F;
... Zuidewind, Peter; + view all
(2022)
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
The Lancet HIV
10.1016/s2352-3018(22)00160-6.
(In press).
|
Turkova, Anna;
White, Ellen;
Kekitiinwa, Adeodata R;
Mumbiro, Vivian;
Kaudha, Elizabeth;
Liberty, Afaaf;
Ahimbisibwe, Grace Miriam;
... Zuidewind, Peter; + view all
(2023)
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
The Lancet Child & Adolescent Health
, 7
(10)
pp. 718-727.
10.1016/s2352-4642(23)00164-5.
|
Turkova, Anna;
Wills, Genevieve H;
Wobudeya, Eric;
Chabala, Chishala;
Palmer, Megan;
Kinikar, Aarti;
Hissar, Syed;
... Crook, Angela M; + view all
(2022)
Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.
New England Journal of Medicine
, 386
(10)
pp. 911-922.
10.1056/nejmoa2104535.
|
Turkova, A;
Chappell, E;
Judd, A;
Goodall, RL;
Welch, SB;
Foster, C;
Riordan, A;
... Collaborative HIV Paediatric Study (CHIPS) Steering Committee; + view all
(2015)
Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort study.
The Lancet HIV
, 2
(12)
e530-e539.
10.1016/S2352-3018(15)00200-3.
|
Turkova, A;
Moore, CL;
Butler, K;
Compagnucci, A;
Saïdi, Y;
Musiime, V;
Nanduudu, A;
... BREATHER (PENTA 16) Trial Group, .; + view all
(2018)
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.
PLoS One
, 13
(4)
, Article e0196239. 10.1371/journal.pone.0196239.
|
Turner, Rebecca M;
Turkova, Anna;
Moore, Cecilia L;
Bamford, Alasdair;
Archary, Moherndran;
Barlow-Mosha, Linda N;
Cotton, Mark F;
... White, Ian R; + view all
(2022)
Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial.
BMC Medical Research Methodology
, 22
, Article 49. 10.1186/s12874-022-01539-3.
|
Uyoga, S;
Mpoya, A;
Olupot-Olupot, P;
Kiguli, S;
Opoka, RO;
Engoru, C;
Mallewa, M;
... Maitland, K; + view all
(2019)
Haematological quality and age of donor blood issued for paediatric transfusion to four hospitals in sub-Saharan Africa.
Vox Sanguinis
, 114
(4)
pp. 340-348.
10.1111/vox.12764.
|
Violari, A;
Cotton, MF;
Kuhn, L;
Schramm, DB;
Paximadis, M;
Loubser, S;
Shalekoff, S;
... Tiemessen, CT; + view all
(2019)
A unique perinatally HIV-infected child with long-term sustained virological control following antiretroviral treatment cessation.
Nature Communications
, 10
, Article 412. 10.1038/s41467-019-08311-0.
|
Waalewijn, Hylke;
Chan, Man K;
Bollen, Pauline DJ;
Mujuru, Hilda A;
Makumbi, Shafic;
Kekitiinwa, Adeodata R;
Kaudha, Elizabeth;
... ODYSSEY Trial Team; + view all
(2022)
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.
The Lancet HIV
10.1016/S2352-3018(21)00292-7.
(In press).
|
Waalewijn, Hylke;
Szubert, Alexander J;
Wasmann, Roeland E;
Wiesner, Lubbe;
Chabala, Chishala;
Bwakura-Dangarembizi, Mutsa;
Makumbi, Shafic;
... Children with HIV in Africa – Pharmacokinetics and Acceptability; + view all
(2023)
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
Clinical Infectious Diseases
, Article ciad267. 10.1093/cid/ciad267.
(In press).
|
Waalewijn, Hylke;
Wasmann, Roeland E;
Bamford, Alasdair;
Gibb, Diana M;
McIlleron, Helen M;
Colbers, Angela;
Burger, David M;
(2024)
Population Pharmacokinetics of Dolutegravir in African Children: Results From the CHAPAS-4 Trial.
Journal of the Pediatric Infectious Diseases Society
10.1093/jpids/piae076.
(In press).
|
Wademan, DT;
Busakwe, L;
Nicholson, TJ;
van der Zalm, M;
Palmer, M;
Workman, J;
Turkova, A;
... Hoddinott, G; + view all
(2019)
Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial.
International Journal of Tuberculosis and Lung Disease
, 23
(12)
pp. 2363-2368.
10.5588/ijtld.19.0115.
|
Walker, S;
Cox, E;
Revill, P;
Musiime, V;
Bwakura-Dangarembizi, M;
Mallewa, J;
Cheruiyot, P;
... Soares, M; + view all
(2020)
The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa.
Journal of the International AIDS Society
, 23
(3)
, Article e25469. 10.1002/jia2.25469.
|
Wasserman, Sean;
Donovan, Joseph;
Kestelyn, Evelyne;
Watson, James A;
Aarnoutse, Robert E;
Barnacle, James R;
Boulware, David R;
... Wilkinson, Robert J; + view all
(2025)
Advancing the chemotherapy of tuberculous meningitis: a consensus view.
The Lancet Infectious Diseases
, 25
(1)
e47-e58.
10.1016/s1473-3099(24)00512-7.
|
Wedderburn, Catherine J;
Weldon, Ella;
Bertran-Cobo, Cesc;
Rehman, Andrea M;
Stein, Dan J;
Gibb, Diana M;
Yeung, Shunmay;
... Donald, Kirsten A; + view all
(2022)
Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis.
The Lancet Child & Adolescent Health
10.1016/s2352-4642(22)00071-2.
(In press).
|
Wedderburn, Catherine J;
Yeung, Shunmay;
Groenewold, Nynke A;
Rehman, Andrea M;
Subramoney, Sivenesi;
Fouche, Jean-Paul;
Joshi, Shantanu H;
... Donald, Kirsten A; + view all
(2024)
Subcortical Brain Volumes and Neurocognitive Function in Children With Perinatal HIV Exposure: A Population-Based Cohort Study in South Africa.
Open Forum Infectious Diseases
, 11
(7)
, Article ofae317. 10.1093/ofid/ofae317.
|
Wedderburn, Catherine J;
Yeung, Shunmay;
Subramoney, Sivenesi;
Fouche, Jean-Paul;
Joshi, Shantanu H;
Narr, Katherine L;
Rehman, Andrea M;
... Donald, Kirsten A; + view all
(2024)
Association of in utero HIV exposure with child brain structure and language development: a South African birth cohort study.
BMC Medicine
, 22
(1)
, Article 129. 10.1186/s12916-024-03282-6.
|
Wedderburn, CJ;
Subramoney, S;
Yeung, S;
Fouche, J-P;
Joshi, SH;
Narr, KL;
Rehman, AM;
... Donald, KA; + view all
(2020)
Neuroimaging young children and associations with neurocognitive development in a South African birth cohort study.
Neuroimage
, 219
, Article 116846. 10.1016/j.neuroimage.2020.116846.
|
Wedderburn, CJ;
Evans, C;
Yeung, S;
Gibb, DM;
Donald, KA;
Prendergast, AJ;
(2019)
Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework.
Current HIV/AIDS Reports
, 16
pp. 501-513.
10.1007/s11904-019-00459-0.
|
Wedderburn, CJ;
Yeung, S;
Rehman, AM;
Stadler, JAM;
Nhapi, RT;
Barnett, W;
Myer, L;
... Donald, KA; + view all
(2019)
Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study.
The Lancet Child & Adolescent Health
10.1016/S2352-4642(19)30250-0.
(In press).
|
White, Ellen;
Kityo, Cissy;
Spyer, Moira J;
Mujuru, Hilda A;
Nankya, Immaculate;
Kekitiinwa, Adeodata R;
Lugemwa, Abbas;
... Turkova, Anna; + view all
(2025)
Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
The Lancet HIV
10.1016/s2352-3018(24)00155-3.
(In press).
|
White, Ian;
Choodari-Oskooei, Babak;
Sydes, Matthew R;
Kahan, Brennan;
McCabe, Leanne;
Turkova, Anna;
Esmail, Hanif;
... Ford, Deborah; + view all
(2022)
Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently.
Clinical Trials
10.1177/17407745221093577.
(In press).
|
Whittaker, C;
Watson, OJ;
Alvarez-Moreno, C;
Angkasekwinai, N;
Boonyasiri, A;
Carlos Triana, L;
Chanda, D;
... Hallett, TB; + view all
(2021)
Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis.
Clinical Infectious Diseases
10.1093/cid/ciab837.
(In press).
|
Writing Group, EuroCoord Kids to Adults Working Group, .;
Writing Group, EuroCoord Data Management and Harmonisation Group, .;
(2016)
Children and young people with perinatal HIV in Europe: epidemiological situation in 2014 and implications for the future.
Eurosurveillance
, 21
(10)
, Article 4. 10.2807/1560-7917.ES.2016.21.10.30162.
|
Young, J;
Psichogiou, M;
Meyer, L;
Ayayi, S;
Grabar, S;
Raffi, F;
Reiss, P;
... Grp, EAIDST; + view all
(2012)
y CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE.
PLoS Medicine
, 9
(3)
, Article e1001194. 10.1371/journal.pmed.1001194.
|
Thesis
Fitzgerald, FCS;
(2017)
Microbial Translocation in children with HIV in Uganda.
Doctoral thesis , UCL (University College London).
|